PREVIOUS
✖
WHO report on antibacterial research
June 20 , 2024
10 days
124
0
- WHO released its annual report titled “2023 Antibacterial agents in clinical and preclinical development: an overview and analysis”.
- India contributes only 1% to the global antibacterial research and development (R&D) pipeline.
- 84% of antibacterial R&D is concentrated in high-income countries, with another 12% in upper-middle-income economies.
- But the lower-middle-income countries including India, are contributing only 4%.
- The new antibacterial agents being developed in China and the Russian Federation are 3% and 2%, respectively.
- India and South Africa are each contributing 1%.
Leave a Reply
Your Comment is awaiting moderation.